Nephrotic syndrome with minimal change disease after the Pfizer-BioNTech COVID-19 vaccine: two cases

被引：11

作者：

Hartley, James Leon ^{[1
]}

Bailey, Neil ^{[2
]}

Sharma, Asheesh ^{[3
]}

Shawki, Howida ^{[4
]}

机构：

[1] Royal Liverpool Univ Hosp, Nephrol, Liverpool, Merseyside, England

[2] Warrington & Halton Teaching Hosp NHS Fdn Trust, Nephrol, Warrington, Cheshire, England

[3] Royal Liverpool & Broadgreen Hosp NHS Trust, Nephrol, Liverpool, Merseyside, England

[4] Royal Liverpool & Broadgreen Univ Hosp NHS Trust, Histopathol, Liverpool, Merseyside, England

来源：

BMJ CASE REPORTS | 2022年 / 15卷 / 03期

关键词：

COVID-19; immunological products and vaccines; renal system; vaccination; immunisation; nephrotic syndrome;

D O I：

10.1136/bcr-2021-244638

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We present two cases of nephrotic syndrome with minimal change disease after the Pfizer-BioNTech COVID-19 vaccine. We discuss the initial presentation, investigation and management of these patients along with a discussion around the current evidence base for vaccine-induced nephrotic syndrome.

引用

页数：5

共 50 条

[21] Multiple sites of thrombosis without thrombocytopenia after a second dose of Pfizer-BioNTech COVID-19 vaccine
Scendoni, Roberto
Petrelli, Cristina
Giustozzi, Mauro
Logullo, Francesco O.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2022, 36
[22] Vulvar Aphthous Ulcer Following Pfizer-BioNTech COVID-19 Vaccine - A Case Report
Drucker, Abigail
Corrao, Kellianne
Gandy, Mallory
JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY, 2022, 35 (02) : 165 - 166
[23] Clinical outcomes of Pfizer-BioNTech COVID-19 vaccine in children and adolescents: A systematic review
Al-Qudimat, Ahmad R.
Al-Zoubi, Raed M.
Elaarag, Mai
Nashwan, Abdulqadir J.
Hamze, Afaf K.
Bawadi, Hiba
Yassin, Aksam
Assim, Aseel
Aboumarzouk, Omar M.
Zarour, Ahmad
Al-Ansari, Abdulla A.
HEALTH SCIENCE REPORTS, 2022, 5 (04)
[24] Immune Thrombocytopenic Purpura Following Pfizer-BioNTech COVID-19 Vaccine in an Elderly Female
Jasaraj, Ranjit B.
Shrestha, Dhan B.
Gaire, Suman
Kassem, Mohammed
CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (08)
[25] Adverse Events with the Pfizer-BioNTech COVID-19 Vaccine among Korean Healthcare Workers
Im, Jae Hyoung
Kim, Eunjung
Lee, Eunyoung
Seo, Yeongju
Lee, Yuran
Jang, Yoonkyoung
Yu, Soyeon
Maeng, Yeonju
Park, Soyeon
Park, Seohee
Kim, Jiah
Lee, Jin-Soo
Baek, Ji Hyeon
YONSEI MEDICAL JOURNAL, 2021, 62 (12) : 1162 - 1168
[26] Pfizer-BioNTech COVID-19 Vaccine in Gynecologic Oncology Patients: A Prospective Cohort Study
Palaia, Innocenza
Caruso, Giuseppe
Di Donato, Violante
Vestri, Annarita
Napoli, Anna
Perniola, Giorgia
Casinelli, Matteo
Alunni Fegatelli, Danilo
Campagna, Roberta
Tomao, Federica
D'Aniello, Debora
Antonelli, Guido
Muzii, Ludovico
VACCINES, 2022, 10 (01)
[27] Considerations in Pfizer-BioNTech COVID-19 vaccine preparation in clinic: Quality vs quantity
Jin, Haksong
Tran, Marleen
Rivero, Josef
Childs, Richard
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2022, 79 (05) : 326 - 328
[28] Recrudescence of severe polyneuropathy after receiving Pfizer-BioNTech COVID-19 vaccine in a patient with a history of eosinophilic granulomatosis with polyangiitis
Gill, Rahul
Rizvi, Macym
Sadiq, Muhammad S.
Feldman, Mark
BMJ CASE REPORTS, 2022, 15 (04)
[29] Systemic capillary leak syndrome (SCLS) after receiving BNT162b2 mRNA COVID-19 (Pfizer-BioNTech) vaccine
Inoue, Masatoshi
Yasue, Yu
Kobayashi, Yoichi
Sugiyama, Yutaka
BMJ CASE REPORTS, 2022, 15 (03)
[30] Rare cutaneous manifestation of COVID-19 infection and Pfizer-BioNTech COVID-19 vaccine with a unique pattern similarity
Fata, Anthony
Jabbour, Georges
Kourie, Hampig
Zoghbi, Marianne
Kassouf, Elia
Zoghbi, Antoine
FUTURE VIROLOGY, 2021, 16 (11) : 741 - 749

← 1 2 3 4 5 →